Tag | Content |
---|
EnhancerAtlas ID | HS054-03996 |
Organism | Homo sapiens |
Tissue/cell | FT246 |
Coordinate | chr3:49414440-49416760 |
SNPs | Number: 2 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
EWSR1-FLI1 | MA0149.1 | chr3:49414695-49414713 | GAAAGGAAGGACGGACGG | + | 6.64 | EWSR1-FLI1 | MA0149.1 | chr3:49414699-49414717 | GGAAGGACGGACGGAAGC | + | 6.8 | NEUROG2 | MA0669.1 | chr3:49416483-49416493 | AACATATGTC | + | 6.02 | PHOX2A | MA0713.1 | chr3:49416399-49416410 | TAATCCAATTA | + | 6.02 | Phox2b | MA0681.1 | chr3:49416399-49416410 | TAATCCAATTA | + | 6.02 | ZNF263 | MA0528.1 | chr3:49414712-49414733 | GAAGCATGAGAGGGGAGGGGA | + | 6.16 |
|
| Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
SE_18986 | chr3:49414110-49416419 | CD4p_CD25-_Il17-_PMAstim_Th | SE_54109 | chr3:49415840-49416388 | Spleen |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 2 | Chromosome | Start | End |
chr3 | 49416021 | 49416209 | chr3 | 49414926 | 49415313 |
|
| Number: 1 | ID | Chromosome | Start | End |
GH03I049377 | chr3 | 49414635 | 49417768 |
|
Enhancer Sequence | ATCCTAGCTA CACAGGAGCA AGAGGCAGGA GAATCGCTTG AACCCGGGAG GCAGAGGTTG 60 TGGTGAGCCG AGATCATGCC ATTGCACTCC AGCCTGGGCA ACAAGAGCGA AACTCCGTCT 120 CAAAAAAGAA AAATCAATTG AGGCCGAGCA CAGTGGTTCA TGTCTGTAAT CCCAACACTT 180 TGGGAGACTG AAGCAGGAGG AATGCTCAGG CCCAGGAGTT AAGAGACCAG CCCTGACAAC 240 ATAGTGAGAC ACTGAGAAAG GAAGGACGGA CGGAAGCATG AGAGGGGAGG GGAGAAAGAA 300 AAGGGCCGGG CGCAGTGGCT CACGCCTATA ATCCCAGCAA TCTGGGAGGC CGAAACAGGT 360 GGACTGCTTG AGAGTCCAGG AGTTCAAGAC GAGCCTGGGA AACATAGTGA AACCCTGTCT 420 CTACTAAAAA TACAAAAAAT TAGCCAGGAG CGGTGGTGCA TGCTAATCAC AGTTACTTGG 480 GAGGCTCAGG TGGGATAATC CCCTGAGCCC TGGAGGTGGA AGCTGCAGTG AGCTGAGATT 540 GCATCACTAC ACTCCAGCCT GGGGAACCCC AGTGAGACAC TGTCTCTAAA AAAAGAAGGA 600 AAAGAAAAAA AAAAAAATCA GCCAGTTGTG GTAGCATGCA CCTGTAGTCC CAGCTACCAA 660 GGAGGCTGAG GTGGGAGGAT TGCTTGAGCC CAGGAGGTGG AGGATGTGGT GAGCTATGAT 720 TGCATCACTG CACTCCAGCC TGGGTGACAG AGTGGAACCT TGTCTCAAAC TCTTATGACT 780 CAACTACAAA AAAGCAGCTT AGGTTGGTGG TCTGGCTCAG GATCTCTTGC AAGGTTGAAA 840 TCATAAAGAA CTCTTTTTGG GCTGGGCACG GTAGCTCACA CCTGTAATCC CAGCACTTTG 900 GGAGGCTGAG GCAAGCAGAA CACTTGAGGT CAGGAGTTCG AGACCAGCCT GACCAACCCA 960 GCAAAACCCC GTTTCTACAA AAAATTCAAA ACTTAGCCGG GTGTGGTGGT GGGCACCTGT 1020 AATCCCAGTT ACTCGGGAGA CTGAGGCAGG AGAATCGCTT GAACCCAGGA GGCAGAAGTT 1080 GCAGTGAGCC CAGATTGTAC CACTGCACTC CAGCCTGGGC AACAGAGCAC TCCAGCCTGG 1140 GCAACAGAGT GAAACTGTGT CTTAAAAAAA AAAAAAAAAA AAAAGAGAGA ACTCCTTCTG 1200 ACATGAAGTA CGCTATTTAT CTATCCATCT ATCTTTTTTT TTTTTTTTTT TTTTTTTGAG 1260 ATGAGGTCTC ACTCTGTCAC CCAGGCTGGA ATGCAGTGGC GTGATCTTGG CTCAATGCAA 1320 TCTCCACCTC CGAGGCTCAA GTGATCCTCC CACTTCAAAT TCCCCAGCAG CTGGGACCAC 1380 AGGCATGCGC CACCACGCCC AGCTAATTTT TGTATTTTTG GCAGAGACAG GGTTTTGCCA 1440 TGTTTCCCAG GCTGGTCTCC AACTCCTGAG CTCAAGTGAT CTACTCGCCT CGGCCTCCCA 1500 CAGTGCTGAG GGATTACAGG CGTGAGCCAC TGCCCATCTA TCTACGCATC TATCCAATCT 1560 ATGTACCTAT CTAACCTATC TATGTGTTTC TCTATTATGT AGTTATTTTC AGAAAGGGTC 1620 TCATTCTGTC ACCAAGGCTG GAATGCAGTG GTGCAATATT GGCTCACTGC AGCCTCTGCC 1680 TCCCAGGCTC AACTCAAGCG ATCCTCCCAC CTCAACCTCT CCAGTAGCTG GGACTACCAG 1740 GCTCCTGCCA CCACAGCTGA CTAATTTTTA TACAGATAGC GTTTCACTAT ATTACCCAGG 1800 CTGGTCTCAA ACTCCTGGGC TCATGCAATC CTCCCGATTC AGCCTCCCAA AGTGCTGGGA 1860 TTACAAGCAT AAGCCACCTC CCCAGGCCTA AATACAGTAT ATAGAAAAAA TTAAAAAATA 1920 AAGAACTCTT ACAATTCAAT AATAAAAAGA CAAATAATCT AATCCAATTA AAAAATGAGC 1980 AAAGGATGTG AGTAGGTATG ACCCTGCAAT TCTATTCCTA GGTATATATC TAAGAGAAAC 2040 AAAAACATAT GTCCACATAA CAACTTGTAC CTCTACATGA ATATTCATAG CAGGATTATT 2100 CATAATATAT TGTCAAAAAA TGTAAAGAAC CCAAATATCC AACAACTGAT GAATATAATA 2160 TATCCATACA ATGGAATGGA ATATTATTCA GCGATAAAGG ATAAAGTACT GATATATGCT 2220 ATAGTATGGA TAGATCTTGG AAATGTTATA TAAGTGAAAG AACCCAGTCA CAAAAACCAA 2280 CATGCATGAT TCCATTTATA TAAAATTGTC CAGAATAAAC 2320
|